<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01057966</url>
  </required_header>
  <id_info>
    <org_study_id>SMA-09-32</org_study_id>
    <nct_id>NCT01057966</nct_id>
  </id_info>
  <brief_title>Bioavailability of Nutrients Contained in Softgel Capsules vs Tablets</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alcon Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a comparison of the bioavailability of nutrients contained in softgel capsules
      vs tablets.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2010</start_date>
  <completion_date type="Actual">September 2011</completion_date>
  <primary_completion_date type="Actual">September 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bioavailability of nutrients</measure>
    <time_frame>1 week for each treatment cross-over period</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Vision</condition>
  <arm_group>
    <arm_group_label>ICAPS AREDS Softgel Capsule - Full Strength</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ICAPS Eye Vitamin and Mineral Supplement - Softgel</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ICAPS AREDS Softgel Capsule - Half Strength</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ICAPS Eye Vitamin and Mineral Supplement - Softgel (half -strength)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ICAPS AREDS coated tablets - Full Strength</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ICAPS Eye Vitamin and Mineral Supplement - Coated Tablets</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>ICAPS Eye Vitamin and Mineral Supplement - Softgel (full strength)</intervention_name>
    <description>Single full strength dose capsule taken one time</description>
    <arm_group_label>ICAPS AREDS Softgel Capsule - Full Strength</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>ICAPS Eye Vitamin and Mineral Supplement - Softgel (half strength)</intervention_name>
    <description>Single half strength dose capsule taken one time</description>
    <arm_group_label>ICAPS AREDS Softgel Capsule - Half Strength</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>ICAPS Eye Vitamin and Mineral Supplement - Coated Tablets (full strength)</intervention_name>
    <description>Single, full strength dose tablet taken one time</description>
    <arm_group_label>ICAPS AREDS coated tablets - Full Strength</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age 18 to 35

          2. Body Mass Index (BMI) 21-27 kg/m2

          3. Must be able to give written informed consent

          4. Subjects must be willing to comply with all study requirements.

          5. Subjects must understand, sign and be given a copy of the written Informed Consent
             form.

        Exclusion Criteria:

          1. Subjects for whom both eyes do not meet all inclusion criteria and either eye meets
             exclusion criteria

          2. Subjects who are pregnant, lactating or planning to be pregnant during the course of
             the study

          3. Subjects with known sensitivity to planned study concomitant medications

          4. Subjects participating in any other ophthalmic drug or device clinical trial within 30
             days of this clinical investigation.

          5. Use of ocular drugs, other than study medications, during the study and within 14 days
             prior to study entry or any other ocular medication
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Contact Alcon Call Center For Trial Locations</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76134</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 27, 2010</study_first_submitted>
  <study_first_submitted_qc>January 27, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 28, 2010</study_first_posted>
  <last_update_submitted>January 31, 2012</last_update_submitted>
  <last_update_submitted_qc>January 31, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 2, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Bioavailability</keyword>
  <keyword>Ocular Vitamins</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

